Acquirer · Corporate
Techmatrix
1$15m$15m0
Photo: Livestock Industries, CSIRO / Wikimedia Commons, CC BY 3.0Techmatrix agrees to take control of pathology AI startup Medmain for about ¥2.3 billion
Techmatrix's subsidiary PSP has been a Medmain shareholder since 2022; together they plan to buy out the startup's other investors and build a combined digital pathology platform.
$15mn/aSeries ACorporate
Latest in Techmatrix
All Techmatrix exitsOpen tracker →
Techmatrix → Medmain$15m< $50m